SARS-CoV-2

Dr Robert Hess: Long Covid After Vaccination

Dr Robert Hess: Long Covid After Vaccination In rare cases, coronavirus vaccines may cause Long Covid–like symptoms. As mentioned the symptomatology of this condition can be very similar to the side-effects and possible long-term consequences of vaccination. While preliminary data suggests that getting yourself vaccinated significantly reduces your risk of succumbing to Long Covid, there…

Read More

Dr Robert Hess: Managing the Covid-19 aftermath

Dr Robert Hess: Managing the Covid-19 aftermath: Detox of the spike-protein. Two full years after the pandemic began, it is now time to consider our next moves. In order to maintain a clear overview, I placed great emphasis on accurate documentation and ongoing information exchange right from the start. This meticulous approach, together with insights…

Read More

Dr Robert Hess: In rare cases

Dr Robert Hess: In rare cases, coronavirus vaccines may cause Long Covid-like symptoms. As mentioned on Long Covid and potential risk factors, the symptomatology of this condition can be very similar to the side-effects and possible long-term consequences of vaccination. While preliminary data suggests that getting yourself vaccinated significantly reduces your risk of succumbing to…

Read More

Dr Robert Hess: Long Covid risk factors

Dr Robert Hess: Long Covid risk factors now identified. According to the latest figures, between 10 and 30 percent of all persons who test positive for SARS-CoV-2 go on to develop long-term symptoms that can last for weeks, months or potentially even years. These can vary greatly depending on the severity of the disease, the…

Read More

Dr Robert Hess: Updates and Revises

Dr Robert Hess: Updates and Revises Section 4 of its Prophylactic concept. In the current circumstances, it is more important than ever to maintain a clear overview. The number of vaccinations and infections, the virus variants in circulation and the available vaccines, the course taken by an infection, possible side-effects and the administration of various…

Read More

Dr Robert Hess: Best medication yet?

Dr Robert Hess: Best medication yet? Paxlovid a potential gamechanger Paxlovid received emergency approval in the USA just before Christmas, and it got the all-clear for use in Europe as early as January. This new medication could help reduce the number of people who fall severely ill with COVID-19, but supply shortages and manufacturing problems…

Read More

Dr Robert Hess: Weekly Omicron Update

Dr Robert Hess: Weekly Omicron Update Our Situation report in the run-up to Christmas The Omicron variant continues on its triumphant march around the globe. According to the World Health Organization, the mutant has already been detected in 89 countries, and more are being added to the list every day. Even in places with high…

Read More

Dr Robert Hess: Weekly Omicron Update

Dr Robert Hess: Weekly Omicron Update Teams of researchers around the world are working hard to understand the new Omicron variant of the coronavirus. It is the most highly differentiated among the five variants that have so far qualified for the World Health Organization classification “variant of concern” since the pandemic began.   The number…

Read More

Dr Robert Hess: How do viruses interfere with the p53 pathway?

Dr Robert Hess: How do viruses – and more particularly SARS-CoV-2 – interfere with the p53 pathway? We look at the strategies employed by viruses against this tumor suppressor gene. Since the onset of the pandemic, research has been conducted into the extent to which SARS-Cov-2 affects the p53 tumor suppressor gene and its pathway….

Read More

Dr Robert Hess: Update on Booster jabs and vaccine breakthroughs.

Dr Robert Hess: Update on Booster jabs and vaccine breakthroughs.   Infection rates in Germany, Austria and the Netherlands have risen to a new and worrying high. Hospitals have had to postpone planned surgical procedures, and intensive care units are rapidly filling up. The situation in Germany is unfortunately a forerunner of what is likely to…

Read More